206-028-1

Applied Filters:

Keyword:'206-028-1'

Showing 1-1 of 1 result for "206-028-1" within Papers

Determination of the efficiency of 8 mg doxazosin XL treatment in patients with an inadequate response to 4 mg doxazosin XL treatment for benign prostatic hyperplasia.

Tanju Keten et al.

Urology, 85(1), 189-194 (2014-12-23)

To compare the efficacy of 4 mg and 8 mg doxazosin XL treatments in patients with benign prostatic hyperplasia-related lower urinary tract symptoms and determine the efficiency of 8 mg in those patients with inadequate response to 4 mg. A

Page 1 of 1